Navigation Links
Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
Date:1/17/2008

BEIJING and CLAREMONT, Calif., Jan. 17 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (KWBT.OB) has completed its annual management meetings including yearend business review, planning for 2008 and employee recognition ceremonies. The meetings commenced in Xiaotangshan, Beijing on January 11, 2008.

Attending were over 50 managers and staff from Kiwa's corporate headquarters in Beijing, and department managers of Kiwa Shandong and Tianjing Kiwa. During the sessions, company management team members gave speeches reviewing achievements in the past year for their departments. Acknowledgment was made of the comprehensive achievements of Kiwa's employees in 2007: significant improvements in revenues, improvements in operating efficiency and margins, updating of the bio-fertilizer factory, development, testing and approval of new products and expanded distribution and marketing efforts.

In addition, management set forth the business goals and described the main tasks for 2008. They outlined the objectives and strategic plans for the year for Kiwa Shandong, Tianjin Kiwa, bio-technology research and development, building the distribution network, financial management, and corporate management targets were set with the expectation of continuing and expanding on the progress of the past year.

During the session, the efforts of 28 individuals was recognized: 4 staff were awarded "Honor for Striving for Kiwa"; 8 staff were awarded as "Prominent Contributor"; 5 were awarded as "Best New Seller"; 11 staff were awarded as "Advanced Worker"; 2 were awarded "Honor for Loyalty". Lastly, representatives of the honored individuals gave speeches expressing their confidence in the bright future of the Company and pledged to work harder to achieve the objectives set forth for 2008.

Mr. Wei Li, Board Chairman and CEO of Kiwa, stated: "The 2007 annual management meeting is the summary of last year and the blueprint for the next year. We were pleased to recognize employees and managers who helped Kiwa achieve excellent results in 2007. This meeting was also the chance to focus everyone on the great development opportunities for Kiwa in 2008. We will continuously and collectively strive for our objective with good faith to create outstanding achievements in 2008."

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at http://www.kiwabiotech.com .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

Tel: +1-626-715-5855

Email: kiwabiotech@gmail.com

Robert Schechter

Equity Communications

Tel: +1-212-499-6809

Email: ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
2. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
3. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
4. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
5. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
6. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
7. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
8. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
9. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
10. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
11. Sinovac Announces Postponement of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):